Expectation that cardio-metabolic modulation with high-dose insulin could improve outcomes were diminished after the neutral results seen in the large Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment and Evaluation-Estudios Clinicos Latino America (CREATE-ECLA) (107). Here, INS is linked to myocardial infarction.